Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cebers

Showing results (51-60 of 66) with videos related to

Pageof 7
Sort By:
Immunology|September 13, 2002
Expression and regulation of the pattern recognition receptors Toll-like receptor-2 and Toll-like receptor-4 in the human placentaUlrika Holmlund, Gvido Cebers, Agneta R Dahlfors, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 5, 2007
Reduced HO-1 protein expression is associated with more severe neurodegeneration after transient ischemia induced by cortical compression in diabetic Goto-Kakizaki ratsTiago J T P Moreira, Aleta Cebere, Gvido Cebers, et al.
Biulleten' Eksperimental'Noi Biologii I Meditsiny|September 1, 1993
[The anticonvulsant properties of glutapyrone--a new type of derivative of amino acid-containing 1,4-dihydropyridines]M N Karpova, S K Germane, G Cebers, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 15, 2005
Prodynorphin transcripts and proteins differentially expressed and regulated in the adult human brainAndrej Nikoshkov, Yasmin L Hurd, Tatiana Yakovleva, et al.
Journal of Alzheimer'S Disease : JAD|February 19, 2016
AZD3293: A Novel, Orally Active BACE1 Inhibitor with High Potency and Permeability and Markedly Slow Off-Rate KineticsSusanna Eketjäll, Juliette Janson, Karin Kaspersson, et al.
Soft Matter|January 24, 2012
Gelation of semiflexible polyelectrolytes by multivalent counterionsElisabeth M Huisman, Qi Wen, Yu-Hsiu Wang, et al.
Toxicology and Applied Pharmacology|July 13, 2013
Comparative effects of sodium channel blockers in short term rat whole embryo cultureMats F Nilsson, Anna-Carin Sköld, Ann-Christin Ericson, et al.
Experimental Cell Research|August 30, 2001
Cytotoxic effects of dynorphins through nonopioid intracellular mechanismsK Tan-No, G Cebers, T Yakovleva, et al.
Microbiology Spectrum|March 30, 2026
Image-based physical characterization of magnetotactic bacteria from an environmental sampleMara Smite, Mihails Birjukovs, Mila Sirinelli-Kojadinovich, et al.
The Journal of Prevention of Alzheimer'S Disease|December 5, 2017
Reversible and Species-Specific Depigmentation Effects of AZD3293, a BACE Inhibitor for the Treatment of Alzheimer's Disease, Are Related to BACE2 Inhibition and Confined to Epidermis and HairG Cebers, T Lejeune, B Attalla, et al.
Pageof 7

Showing results (51-60 of 66) with videos related to

Sort By:
Pageof 7
Immunology|September 13, 2002
Expression and regulation of the pattern recognition receptors Toll-like receptor-2 and Toll-like receptor-4 in the human placentaUlrika Holmlund, Gvido Cebers, Agneta R Dahlfors, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 5, 2007
Reduced HO-1 protein expression is associated with more severe neurodegeneration after transient ischemia induced by cortical compression in diabetic Goto-Kakizaki ratsTiago J T P Moreira, Aleta Cebere, Gvido Cebers, et al.
Biulleten' Eksperimental'Noi Biologii I Meditsiny|September 1, 1993
[The anticonvulsant properties of glutapyrone--a new type of derivative of amino acid-containing 1,4-dihydropyridines]M N Karpova, S K Germane, G Cebers, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 15, 2005
Prodynorphin transcripts and proteins differentially expressed and regulated in the adult human brainAndrej Nikoshkov, Yasmin L Hurd, Tatiana Yakovleva, et al.
Journal of Alzheimer'S Disease : JAD|February 19, 2016
AZD3293: A Novel, Orally Active BACE1 Inhibitor with High Potency and Permeability and Markedly Slow Off-Rate KineticsSusanna Eketjäll, Juliette Janson, Karin Kaspersson, et al.
Soft Matter|January 24, 2012
Gelation of semiflexible polyelectrolytes by multivalent counterionsElisabeth M Huisman, Qi Wen, Yu-Hsiu Wang, et al.
Toxicology and Applied Pharmacology|July 13, 2013
Comparative effects of sodium channel blockers in short term rat whole embryo cultureMats F Nilsson, Anna-Carin Sköld, Ann-Christin Ericson, et al.
Experimental Cell Research|August 30, 2001
Cytotoxic effects of dynorphins through nonopioid intracellular mechanismsK Tan-No, G Cebers, T Yakovleva, et al.
Microbiology Spectrum|March 30, 2026
Image-based physical characterization of magnetotactic bacteria from an environmental sampleMara Smite, Mihails Birjukovs, Mila Sirinelli-Kojadinovich, et al.
The Journal of Prevention of Alzheimer'S Disease|December 5, 2017
Reversible and Species-Specific Depigmentation Effects of AZD3293, a BACE Inhibitor for the Treatment of Alzheimer's Disease, Are Related to BACE2 Inhibition and Confined to Epidermis and HairG Cebers, T Lejeune, B Attalla, et al.
Pageof 7